SEARCH

SEARCH BY CITATION

References

  • 1
    Manchikanti L, Helm S 2nd, Fellows B, et al. Opioid epidemic in the United States. Pain Physician 2012;15(3 Suppl):ES938.
  • 2
    Maxwell JC. The prescription drug epidemic in the United States: a perfect storm. Drug Alcohol Rev 2011;30:26470.
  • 3
    Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. Available at: http://www.samhsa.gov/data/nsduh/2k11results/nsduhresults2011.htm. Accessed Dec 1, 2013.
  • 4
    Warner M, Chen LH, Makuc DM, Anderson RN, Miniño AM. Drug poisoning deaths in the United States, 1980-2008. NCHS Data Brief 2011;81:18.
  • 5
    Phillips DM. JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations. JAMA 2000;284:4289.
  • 6
    Cantrill SV, Brown MD, Carlisle RJ, et al. Clinical policy: critical issues in the prescribing of opioids for adult patients in the emergency department. Ann Emerg Med 2012;60:499525.
  • 7
    Pletcher MJ, Kertesz SG, Kohn MA, et al. Trends in opioid prescribing by race/ethnicity for patients seeking care in U.S. emergency departments. JAMA 2008;299:708.
  • 8
    Centers for Disease Control and Prevention. Ambulatory Health Care Data. About the Ambulatory Health Care Surveys. Available at: http://www.cdc.gov/nchs/ahcd/about_ahcd.htm. Accessed Dec 1, 2013.
  • 9
    Kelly LE, Rieder M, van den Anker J, et al. More codeine fatalities after tonsillectomy in North American children. Pediatrics 2012;129:e13437.
  • 10
    Koczmara C, Perri D, Hyland S, Rousseaux L. Meperidine (Demerol) safety issues. Dynamics 2005;16:812.
  • 11
    Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington DC: National Academies Press, 2011.
  • 12
    Schwartz RK, Soumerai SB, Avorn J. Physician motivations for nonscientific drug prescribing. Soc Sci Med 1989;28:57782.
  • 13
    Geiderman JM. Keeping lists and naming names: habitual patient files for suspected nontherapeutic drug-seeking patients. Ann Emerg Med 2003;41:87381.
  • 14
    Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:75462.
  • 15
    Edlow JA, Panagos PD, Godwin SA, et al. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute headache. Ann Emerg Med 2008;52:40736.
  • 16
    Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med 1980;302:123.
  • 17
    Perry S. Undermedication for pain on a burn unit. Gen Hosp Psychiatry 1984;6:30816.
  • 18
    Perry SW. Irrational attitudes toward addicts and narcotics. Bull N Y Acad Med 1985;61:70627.
  • 19
    Varney SM, Bebarta VS. Opioid-induced hyperalgesia-worsening pain in opioid-dependent patients. Am J Emerg Med 2013;31:458.
  • 20
    Brush DE. Complications of long-term opioid therapy for management of chronic pain: the paradox of opioid-induced hyperalgesia. J Med Toxicol 2012;8:38792.
  • 21
    Anderson KO, Green CR, Payne R. Racial and ethnic disparities in pain: causes and consequences of unequal care. J Pain 2009;10:1187204.
  • 22
    Substance Abuse and Mental Health Services Administration. The NSDUH Report: Nonmedical Use of Prescription Pain Relievers, 2004. Available at: http://www.samhsa.gov/data/2k4/pain/pain.htm. Accessed Dec 1, 2013.
  • 23
    Simoni-Wastila L, Ritter G, Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse 2004;39:123.
  • 24
    Department of Health and Human Services, Food and Drug Administration. Draft blueprint for prescriber education for long-acting/extended-release opioid class-wide risk evaluation and mitigation strategy (76 FR 68766). 2011; Federal Register Volume 76, Issue 215.
  • 25
    New York State Department of Health. New York's Medical Conduct Program. Pain Management: A Guide for Physicians. Available at: http://www.health.ny.gov/publications/4179.pdf. Accessed Dec 1, 2013.
  • 26
    Neven DE, Sabel JC, Howell DN, et al. The development of the Washington State emergency department opioid prescribing guidelines. J Med Toxicol 2012;8:3539.
  • 27
    Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician 2012;15:ES6792.
  • 28
    Gugelmann HM, Perrone J. Can prescription drug monitoring programs help limit opioid abuse? JAMA 2011;306:22589.
  • 29
    Baehren DF, Marco CA, Droz DE, et al. A statewide prescription monitoring program affects emergency department prescribing behaviors. Ann Emerg Med 2010;56:1923.
  • 30
    Fortuna RJ, Robbins BW, Caiola E, et al. Prescribing of controlled medications to adolescents and young adults in the United States. Pediatrics 2010;126:11081116.
  • 31
    McCabe SE, West BT, Teter CJ, et al. Medical and nonmedical use of prescription opioids among high school seniors in the United States. Arch Pediatr Adolesc Med 2012;166:797802.
  • 32
    Cicero TJ, Surratt H, Inciardi JA, et al. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf 2007;16:82740.
  • 33
    McCaig LF, Burt CW. Understanding and interpreting the National Hospital Ambulatory Medical Care Survey: key questions and answers. Ann Emerg Med 2012;60:71621.